ENDOMETRIAL NEOPLASM

This adverse event was reported 74 times

ENDOMETRIAL NEOPLASM is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 ECALLANTIDE 1 0.0005
1 PLECANATIDE 1 0.0005
2 TELMISARTAN AND HYDROCHLOROTHIAZIDE 1 0.0004
3 OXYMETAZOLINE HYDROCHLORIDE 2 0.0004
4 ALISKIREN HEMIFUMARATE 2 0.0003
5 SELINEXOR 2 0.0002
6 MIFEPRISTONE 1 0.0002
7 NORETHINDRONE 1 0.0002
8 SEVELAMER CARBONATE 2 0.0002
9 PHENTERMINE AND TOPIRAMATE 1 0.0002
See all drugs enriched for association with ENDOMETRIAL NEOPLASM